EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A proposed population‑based justice model for ethical gene transfer expanded access policies

Benjamin Slabaugh

Cell and Gene Therapy Insights · 12.05.2026 · 12 (3) · 355–370

DOI: 10.18609/cgti.2026.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell and Gene Therapy Insights, online erschienen am 12.05.2026. Verfasst von Benjamin Slabaugh. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Investigational clinical programs using somatic gene‑altering therapies to treat rare and ultra‑rare diseases with unmet need can carry greater risk than other modalities due to emerging technologies with limited safety data and the irreversible nature of the treatments that may rule out future approved gene treatments. The window of opportunity for patients affected by these diseases is narrow and is affected by variables like availability, manufacturing and delivery constraints, and limited research programs. Individuals with life threatening genetic conditions may seek to gain access to unapproved experimental products and processes outside of a clinical trial. In isolation, arguments for expanded access from autonomy offer insufficient grounds to introduce additional risk to a promising clinical development pathway that could result in treatment ultimately being closed to others. The Belmont principle of justice can be expanded beyond equitable enrollment and representation to also incorporate distribution and access at the population level to alleviate suffering, ameliorate adverse associated outcomes, and to prevent early mortality associated with rare genetic conditions. The broadest interpretation of equality of opportunity under distributive justice requires that ethically sound manufacturer policies governing expanded access should increase the range of opportunities for genetically disadvantaged present and future populations to receive a treatment they otherwise would not.

Zitieren

APA

Slabaugh, B. (2026). A proposed population‑based justice model for ethical gene transfer expanded access policies. Cell and Gene Therapy Insights, 12(3), 355–370. https://doi.org/10.18609/cgti.2026.040

Vancouver

Slabaugh B. A proposed population‑based justice model for ethical gene transfer expanded access policies. Cell and Gene Therapy Insights. 2026;12(3):355–370. doi:10.18609/cgti.2026.040

BibTeX
@article{Slabaugh2026,
  author = {Slabaugh, Benjamin},
  title = {A proposed population‑based justice model for ethical gene transfer expanded access policies},
  journal = {Cell and Gene Therapy Insights},
  year = {2026},
  volume = {12},
  number = {3},
  pages = {355–370},
  doi = {10.18609/cgti.2026.040}
}
Kostenlos starten →